At AACR 2023, Researchers Report on Promising Novel Antitumor Strategies in Early-Phase Clinical Trials

At the American Association for Cancer Research (AACR) Annual Meeting 2023’s third clinical trials plenary session, Promising Novel Antitumor Strategies in Early Phase Clinical Trials, researchers showcased four anti-tumor treatments that have shown early promise. Below is a look at the trials reported in the session, which was originally presented Monday, April 17, and can be viewed on the virtual meeting platform by registered Annual Meeting participants through July 19, 2023.

Login Or Register To Read Full Story